Direktif untuk semua produk yang mengandungi mesalazine: Pengemaskinian sisip bungkusan dan risalah maklumat ubat untuk pengguna (RiMUP) dengan amaran kesan advers photosensitivity.
The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.
Mobile Web :
Site Last Modified
Last Modified: Monday 25 September 2023, 14:20:55.